8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
GE HealthCare reports 5.7% second-quarter revenue growth and reaffirms 2026 outlook
Filed with the SEC on · Summarized by InvestorsBot
GE HealthCare reported second-quarter 2026 revenue of $5.3 billion, up 5.7% year over year, with diluted EPS rising 16.5% to $1.24 and adjusted EPS increasing 6.6% to $1.13; results included tariff refunds that benefited net income by $129 million. Organic orders rose a record 11.1%, backlog reached $23.9 billion, and the company reaffirmed full-year guidance for 3.0%-4.0% organic revenue growth, adjusted EPS of $4.80-$5.00, and free cash flow of approximately $1.6 billion, while Patient Care Solutions revenue fell 13.3% and posted a segment EBIT loss.